Skip to Main Content

Paper Details

ABCC3 Expressed by CD56<sup>dim</sup> CD16<sup>+</sup> NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy.
Int J Mol Sci
16
2019
ABCC3, ABCC3 gene, ABCC3 protein, CD16, CD16+, CD56dim, CD56dim CD16+ NK Cells, CD56dim CD16+ NK cells, CD56dim NK cells, DelC, GBM, Glioblastoma, IFN-, NK cell, NK cells, NRF2, Patients, TMZ, antitumor effector cells, cancers, cytosine, dendritic cell, glioblastoma, glioma, mice, multidrug-resistance protein ABCC3, patient, patients, promoter region, rs35467079, single nucleotide polymorphism, temozolomide
Author NameAffiliation
Marica EoliFondazione IRCCS Istituto Neurologico Carlo Besta
Gaetano FinocchiaroFondazione IRCCS Istituto Neurologico Carlo Besta
Gaetano FinocchiaroFondazione IRCCS Istituto Neurologico Carlo Besta
  • 1 - 3

Datasets

Release 1.2